Evidence for an involvement of the ubiquitin‐like modifier ISG15 in MHC class I antigen presentation

The IFN stimulated gene 15 (ISG15) encodes a 15‐kDa ubiquitin‐like protein, that is induced by type I IFNs and is conjugated to the bulk of newly synthesized polypeptides at the ribosome. ISG15 functions as an antiviral molecule possibly by being covalently conjugated to viral proteins and disturbing virus particle assembly. Here, we have investigated the effect of ISGylation on degradation and antigen presentation of viral and cellular proteins. ISGylation did not induce proteasomal degradation of bulk ISG15 target proteins neither after overexpressing ISG15 nor after induction by IFN‐β. The MHC class I cell surface expression of splenocytes derived from ISG15‐deficient mice or mice lacking the catalytic activity of the major de‐ISGylating enzyme USP18 was unaltered as compared to WT mice. Fusion of ubiquitin or FAT10 to the long‐lived nucleoprotein (NP) of lymphocytic choriomeningitis virus accelerated the proteasomal degradation of NP while fusion to ISG15 did not detectably speed up NP degradation. Nevertheless, MHC‐I restricted presentation of two epitopes of NP were markedly enhanced when it was fused to ISG15 similarly to fusion with ubiquitin or FAT10. Thus, we provide evidence that ISG15 can enhance the presentation of antigens on MHC‐I most likely by promoting co‐translational antigen processing.

[1]  K. Knobeloch,et al.  ISG15, an Interferon-Stimulated Ubiquitin-Like Protein, Is Not Essential for STAT1 Signaling and Responses against Vesicular Stomatitis and Lymphocytic Choriomeningitis Virus , 2005, Molecular and Cellular Biology.

[2]  J. Huibregtse,et al.  Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. , 2017, Molecular cell.

[3]  R. Schmidt,et al.  Identification of Interferon-Stimulated Gene 15 as an Antiviral Molecule during Sindbis Virus Infection In Vivo , 2005, Journal of Virology.

[4]  D. Lenschow,et al.  Novel Mode of ISG15-Mediated Protection against Influenza A Virus and Sendai Virus in Mice , 2014, Journal of Virology.

[5]  A. Goldberg,et al.  A role for the ubiquitin-dependent proteolytic pathway in MHC class l-restricted antigen presentation , 1993, Nature.

[6]  J. Zhang,et al.  DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction , 1997, Journal of virology.

[7]  M. van den Broek,et al.  Stable Antigen Is Most Effective for Eliciting CD8+ T-Cell Responses after DNA Vaccination and Infection with Recombinant Vaccinia Virus In Vivo , 2012, Journal of Virology.

[8]  R. Lippé,et al.  Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection , 2009, Nature Immunology.

[9]  D. Bogunovic,et al.  ISG15: In Sickness and in Health. , 2017, Trends in immunology.

[10]  R. Krug,et al.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein , 2004 .

[11]  M. Groettrup,et al.  FAT10ylation as a signal for proteasomal degradation. , 2014, Biochimica et biophysica acta.

[12]  Anjali Rohatgi,et al.  ISG15 Is Critical in the Control of Chikungunya Virus Infection Independent of UbE1L Mediated Conjugation , 2011, PLoS pathogens.

[13]  K. Kharbanda,et al.  Acetaldehyde Disrupts Interferon Alpha Signaling in Hepatitis C Virus-Infected Liver Cells by Up-Regulating USP18. , 2016, Alcoholism, clinical and experimental research.

[14]  J. Yewdell,et al.  Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? , 1996, Journal of immunology.

[15]  S. Desai,et al.  Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective , 2015, Oncotarget.

[16]  A. Haas,et al.  Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. , 1987, The Journal of biological chemistry.

[17]  K. Hofmann,et al.  Activating the ubiquitin family: UBA6 challenges the field. , 2008, Trends in biochemical sciences.

[18]  H. Yokosawa,et al.  Identification and Herc5-mediated ISGylation of novel target proteins. , 2006, Biochemical and biophysical research communications.

[19]  Dong-er Zhang,et al.  Interferon-stimulated gene 15 and the protein ISGylation system. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[20]  A. Goldberg,et al.  Degradation of cell proteins and the generation of MHC class I-presented peptides. , 1999, Annual review of immunology.

[21]  E. Chiocca,et al.  Interferon-stimulated Gene 15 (ISG15) and ISG15-linked Proteins Can Associate with Members of the Selective Autophagic Process, Histone Deacetylase 6 (HDAC6) and SQSTM1/p62* , 2014, The Journal of Biological Chemistry.

[22]  D. Krappmann,et al.  Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF‐&kgr;B activation , 2017, Molecular immunology.

[23]  E. Borden,et al.  High-throughput Immunoblotting , 2003, The Journal of Biological Chemistry.

[24]  J. Huibregtse,et al.  The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15 , 2010, Molecular Cell.

[25]  K. Knobeloch,et al.  Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy , 2014, Circulation.

[26]  P. Kloetzel,et al.  The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation , 2012, Cellular and Molecular Life Sciences.

[27]  K. Knobeloch,et al.  Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance , 2015, Proceedings of the National Academy of Sciences.

[28]  J. Yewdell,et al.  Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands , 2011, Cellular and Molecular Life Sciences.

[29]  S. Pestka,et al.  Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. , 2006, Cancer research.

[30]  M. Groettrup,et al.  Newly translated proteins are substrates for ubiquitin, ISG15, and FAT10 , 2017, FEBS letters.

[31]  Steven Gygi,et al.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Xiao-Ling Li,et al.  Proteasomes Modulate Conjugation to the Ubiquitin-like Protein, ISG15* , 2003, The Journal of Biological Chemistry.

[33]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Jonathan W. Yewdell,et al.  Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.

[35]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[36]  J. Paul Robinson,et al.  Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) , 2019, European journal of immunology.

[37]  K. Rock,et al.  Cellular protein is the source of cross-priming antigen in vivo. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Casanova,et al.  Mycobacterial Disease and Impaired IFN-γ Immunity in Humans with Inherited ISG15 Deficiency , 2012, Science.

[39]  M. Buchmeier,et al.  Cutting Edge: Neosynthesis Is Required for the Presentation of a T Cell Epitope from a Long-Lived Viral Protein1 , 2001, The Journal of Immunology.

[40]  R. Krug,et al.  Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins , 2016, Nature Communications.

[41]  R. Krug,et al.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Seung Hyeun Ka,et al.  ISG15 modification of filamin B negatively regulates the type I interferon‐induced JNK signalling pathway , 2009, EMBO reports.

[43]  N. Krishna,et al.  Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome Degradation , 2004, Molecular and Cellular Biology.

[44]  D. Lenschow,et al.  The Antiviral Activities of ISG15 , 2013, Journal of Molecular Biology.

[45]  A. Haas,et al.  Crystal Structure of the Interferon-induced Ubiquitin-like Protein ISG15*[boxs] , 2005, Journal of Biological Chemistry.

[46]  N. Sze,et al.  HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Ming Yan,et al.  Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis , 2015, Scientific Reports.

[48]  R. Krug,et al.  Herc5, an Interferon-induced HECT E3 Enzyme, Is Required for Conjugation of ISG15 in Human Cells* , 2006, Journal of Biological Chemistry.

[49]  D. Lane,et al.  Isg15 controls p53 stability and functions , 2014, Cell cycle.

[50]  S. Ramanujam,et al.  In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. , 1996, Journal of immunology.

[51]  J. Zimmerman,et al.  A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies , 2017, Scientific Reports.

[52]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.